Furthermore, [18F]FDG PET/CT provides valuable prognostic data, and it is preferred for evaluating response to treatment [104,105], even though low hexokinase-2 expression in MM may cause false-negative results [106]. Here, HK2 is linked to Miyoshi myopathy.